Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial-Reference-Cited by-同舟云学术

Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial

Published:2017-11 Issue:11 Volume:18 Page:1532-1542
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Beer Tomasz M,Hotte Sebastien J,Saad Fred,Alekseev Boris,Matveev Vsevolod,Fléchon Aude,Gravis Gwenaelle,Joly Florence,Chi Kim N,Malik Zafar,Blumenstein Brent,Stewart Patricia S,Jacobs Cindy A,Fizazi Karim

Publisher

Elsevier BV

Subject

Oncology

Reference42 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

3. European cancer mortality predictions for the year 2016 with focus on leukaemias;Malvezzi;Ann Oncol,2016

4. Cancer Facts & Figures 2016,2016

5. Prostate cancer: ESMO Consensus Conference Guidelines 2012;Horwich;Ann Oncol,2013

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative Chinese-Western medicine strategy to overcome docetaxel resistance in prostate cancer;Journal of Ethnopharmacology;2024-09

2. Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress;Molecular Therapy - Nucleic Acids;2024-09

3. Decoding CLU (Clusterin): Conquering cancer treatment resistance and immunological barriers;International Immunopharmacology;2024-08

4. From biology to the clinic — exploring liver metastasis in prostate cancer;Nature Reviews Urology;2024-04-26

5. ATPase Copper Transporting Beta (ATP7B) Is a Novel Target for Improving the Therapeutic Efficacy of Docetaxel by Disulfiram/Copper in Human Prostate Cancer;Molecular Cancer Therapeutics;2024-02-28